| 000 | 01739 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513145551.0 | ||
| 264 | 0 | _c19980812 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.1998.16.7.2426 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGore, M | |
| 245 | 0 | 0 |
_aRandomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cJul 1998 |
||
| 300 |
_a2426-34 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMainwaring, P | |
| 700 | 1 | _aA'Hern, R | |
| 700 | 1 | _aMacFarlane, V | |
| 700 | 1 | _aSlevin, M | |
| 700 | 1 | _aHarper, P | |
| 700 | 1 | _aOsborne, R | |
| 700 | 1 | _aMansi, J | |
| 700 | 1 | _aBlake, P | |
| 700 | 1 | _aWiltshaw, E | |
| 700 | 1 | _aShepherd, J | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 16 _gno. 7 _gp. 2426-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1998.16.7.2426 _zAvailable from publisher's website |
| 999 |
_c9633234 _d9633234 |
||